ImmunityBio’s ANKTIVA shows promise, but modest growth, high cash burn, and rising competition raise red flags. Read why IBRX stock is a sell.

A Queensland doctor adopts emerging technology to spare more patients from the scalpel as a fear of needles and the risk of ...

Lung Cancer is the most deadly cancer in the U.S. About 70% of people who develop lung cancer pass away within five years, ...

BILOXI, Miss. (WLOX) - The Mississippi State Department of Health (MSDH) and the Mississippi Partnership for Comprehensive Cancer Control (MP3C) announced Karen Sock as the new Coalition Chair for the ...

Research team finds gold—microscopic, nanosized gold floating in the bloodstream, AKA Extracellular vesicles (EVs), which ...

Ghali Belkahia, a young Moroccan physician excelling in the demanding field of high-precision urological surgery, has ...

Exclusive interview with Dr Charlie Teo reveals the real story behind Australia's most talked-about neurosurgeon and his $51M ...